Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium

BackgroundTechnetium-99m-labeled myocardial perfusion tracers allow simultaneous assessment of myocardial perfusion and left ventricular function by electrocardiography-gated scan. This study was performed to determine whether dobutamine stress electrocardiography-gated tetrofosmin single photon emission computed tomography (SPECT) can identify viable (as defined by positron emission tomography [PET]) but dysfunctional myocardium with contractile reserve.Methods and ResultsThirty-five patients with myocardial infarction underwent resting electrocardiography-gated SPECT and fluorodeoxyglucose (FDG) PET. The relative uptakes of tetrofosmin (%tetrofosmin) and FDG (%FDG) were calculated. Wall motion in 9 left ventricular segments was assessed at rest and during dobutamine stress on a 3-dimensional cine-mode display created with automatic left ventricular function analysis software. A total of 129 dysfunctional segments were analyzed. Forty-five (48.9%) of 92 segments with % tetrofosmin of 50% or greater and only 4 (10.8%) of 37 segments with % tetrofosmin less than 50% had contractile reserves (P < 0001). The sensitivity, specificity, and predictive accuracy of % tetrofosmin of 50% or greater for detecting %FDG of 50% or greater were 85.7%, 74%, and 82.9%, respectively. The incidence of the presence of contractile reserve rose with increasing magnitude of %FDG. The sensitivity, specificity, and predictive accuracy of the presence of contractile reserve for detecting %FDG of 50% or greater were 43.9%, 80.6%, and 52.7%, respectively.ConclusionsDobutamine stress electrocardiography-gated SPECT can identify viable (as defined by PET) but dysfunctional myocardium with contractile reserve.

[1]  R. Senior,et al.  Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging , 1999, Heart.

[2]  M. Yoshiyama,et al.  Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[3]  S. Nekolla,et al.  99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: additional value of gated SPECT. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  M. Yoshiyama,et al.  Detection of a biphasic response of hibernating myocardium by dobutamine-stress electrocardiography-gated technetium-99m-tetrofosmin single photon emission computed tomography--a case report. , 1999, Japanese circulation journal.

[5]  J. Pepper,et al.  Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. , 1998, Circulation.

[6]  S. Vatner,et al.  Hibernating myocardium. , 1998, The New England journal of medicine.

[7]  C. Degueldre,et al.  Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. , 1997, Journal of the American College of Cardiology.

[8]  D. Berman,et al.  Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. , 1997, Journal of the American College of Cardiology.

[9]  W. Smith,et al.  Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing. , 1997, Circulation.

[10]  N Tonami,et al.  Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. , 1997, Journal of the American College of Cardiology.

[11]  I Buvat,et al.  A "hybrid" method for measuring myocardial wall thickening from gated PET/SPECT images. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  E. Erdmann,et al.  Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. , 1996, Journal of the American College of Cardiology.

[13]  K. Williams,et al.  Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. , 1996, Journal of the American College of Cardiology.

[14]  J. Taki,et al.  Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  D. Berman,et al.  Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  R. Pickett,et al.  Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[17]  G Germano,et al.  Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  F J Ten Cate,et al.  Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. , 1995, Circulation.

[19]  A. Soricelli,et al.  Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. , 1995, Circulation.

[20]  V. Dilsizian,et al.  Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. , 1995, Circulation.

[21]  W. Zoghbi,et al.  Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.

[22]  J. Nuyts,et al.  Histological Alterations in Chronically Hypoperfused Myocardium: Correlation With PET Findings , 1994, Circulation.

[23]  M. Schwaiger,et al.  Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. , 1994, Journal of the American College of Cardiology.

[24]  E G DePuey,et al.  Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  H Feigenbaum,et al.  Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.

[26]  F. Smith,et al.  Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  A. Lammertsma,et al.  A New Strategy for the Assessment of Viable Myocardium and Regional Myocardial Blood Flow Using 15O‐Water and Dynamic Positron Emission Tomography , 1992, Circulation.

[28]  S L Bacharach,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.

[29]  P. Rigo,et al.  Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[30]  P. Marzullo,et al.  A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy--results in normal subjects. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  T. Faber,et al.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. , 1989, Circulation.

[32]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[33]  G Osakada,et al.  Nonuniformity of inner and outer systolic wall thickening in conscious dogs. , 1985, The American journal of physiology.

[34]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.